Hot Features
Premium
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Zeitraum:
Zeichenmodus:
| Volumen | 573.989 |
|
|||||
| News | - | ||||||
| Tageshoch | 48,23 | Niedrig Hoch |
|||||
| Tagestief | 46,51 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Janux Therapeutics Inc | JANX | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,29 | 0,62% | 47,39 | 06:00:13 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 47,08 | 46,51 | 48,23 | 47,39 | 47,10 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 10.386 | 573.989 | US$ 47,38 | US$ 27.195.057 | - | 5,65 - 58,6936 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:30:14 | 1 | US$ 47,50 | USD |
Option-Flow Janux Therapeutics (JANX)
Finanzwerte JANX
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 2,45B | 51,66M | - | 8,08M | -58,29M | -1,13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Janux Therapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 08.3.2024 | 22:47 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 08.3.2024 | 22:23 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 08.3.2024 | 22:11 | Edgar (US Regulatory) | Form 8-K - Current report |
| 08.3.2024 | 22:01 | Business Wire | Janux Therapeutics Reports Fourth Quarter and Full Year 2023.. |
| 29.2.2024 | 23:30 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 29.2.2024 | 23:11 | Edgar (US Regulatory) | Form 8-K - Current report |
| 29.2.2024 | 07:22 | Business Wire | Janux Therapeutics Announces Pricing of $296.5 Million.. |
| 29.2.2024 | 03:55 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
| 28.2.2024 | 23:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 28.2.2024 | 03:50 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 27.2.2024 | 23:23 | Edgar (US Regulatory) | Form 8-K - Current report |
| 27.2.2024 | 23:00 | Business Wire | Janux Therapeutics Announces Proposed Public Offering of.. |
Forum Janux Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
JANX Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 48,60 | 50,42 | 44,71 | 48,64 | 726.097 | -1,21 | -2,49% |
| 1 Monat | 37,62 | 56,27 | 34,63 | 46,81 | 867.245 | 9,77 | 25,97% |
| 3 Monate | 8,29 | 58,6936 | 7,79 | 44,20 | 1.004.288 | 39,10 | 471,65% |
| 6 Monate | 6,16 | 58,6936 | 5,65 | 40,05 | 527.957 | 41,23 | 669,32% |
| 1 Jahr | 14,66 | 58,6936 | 5,65 | 34,94 | 319.631 | 32,73 | 223,26% |
| 3 Jahre | 34,00 | 58,6936 | 5,65 | 28,92 | 186.576 | 13,39 | 39,38% |
| 5 Jahre | 34,00 | 58,6936 | 5,65 | 28,92 | 186.576 | 13,39 | 39,38% |
